AI-assisted analysis of the earnings call, per our editorial policy. Informational only — not investment advice.

Arteris (AIP) Q1 2023: FlexNOC 5 Launch Targets 20% ACV Growth Amid Automotive and AI Tailwinds

Arteris opened 2023 with a 20% adjusted ACV plus royalty increase, propelled by automotive and AI customer momentum. The FlexNOC 5 launch and expanded OEM wins signal deepening penetration across both automotive and high-performance computing. Management’s full-year visibility and disciplined cost controls set the stage for a second-half inflection, with product innovation and customer diversification balancing macro headwinds.

Summary

  • Automotive and AI Demand Drives Expansion: New OEM wins and AI design activity are broadening end-market exposure.
  • FlexNOC 5 to Lift Second-Half Results: Next-gen product launch is set to meaningfully raise ASPs and ACV.
  • Execution Hinges on Cash Discipline and Macro Resilience: Cost management and 80% revenue visibility support steady full-year outlook.

Business Overview

Arteris provides network-on-chip (NoC) intellectual property (IP) and system-on-chip (SoC) integration automation solutions to semiconductor and systems companies. The company generates revenue through a mix of IP license fees, design starts, and trailing royalties, with major segments including automotive, AI/machine learning, enterprise computing, and consumer electronics. Its technology is embedded in advanced chip designs, enabling customers to achieve improved performance, power efficiency, and design productivity.

Performance Analysis

Arteris posted first-quarter revenue growth of 12% year-over-year and 17% sequentially, with ACV (annual contract value) plus trailing royalties reaching $54.8 million, up 20% YoY when adjusted for prior customer exits. The company added seven new customers and 22 design starts, underscoring sustained demand for its NoC IP across core verticals. Automotive and enterprise computing led design wins, while royalty revenue was anchored by automotive and consumer electronics.

Gross margin remained robust at 91% GAAP (92% non-GAAP), reflecting the high-value, software-centric IP model. Operating expenses rose due to ongoing R&D and sales investments, pushing non-GAAP operating loss to $5.6 million. Free cash flow was negative $8.5 million, as expected, with management reiterating a path to breakeven for the remainder of the year. The balance sheet remains solid with $63.4 million in cash and equivalents.

  • Automotive OEM Penetration: Four new automotive OEM design wins, including three new car companies across the US, Europe, and APAC, highlight OEM engagement.
  • AI and Machine Learning Momentum: Multiple global AI customer deals, including 10th Storrent and Accelera AI, reinforce Arteris’ positioning in high-growth compute segments.
  • FlexNOC 5 Early Access: Feature-complete version delivered to customers, with full production release expected in Q2 to drive H2 revenue growth.

Segment diversification and high-margin product mix continue to underpin resilience, while macro and China headwinds remain a drag on royalty and startup customer activity.

Executive Commentary

"We are pleased to report that in the year to date, Arteris has secured four OEM design wins, including three new car companies across the US, Europe, and APAC. These new relationships demonstrate Arteris' ability to engage across the broader global automotive supply chain."

Charlie Janik, Chief Executive Officer

"Total revenue from the first quarter was $13.2 million, up 12% year-over-year and 17% sequentially...We have continued to achieve significant operating leverage in G&A expense."

Nick Hawkins, Chief Financial Officer

Strategic Positioning

1. FlexNOC 5 Launch and ASP Expansion

FlexNOC 5, Arteris’ next-generation physically aware NoC IP, directly addresses sub-16nm SoC design complexity by enabling earlier physical effect estimation. This innovation is expected to raise average selling prices (ASPs) and drive meaningful ACV uplift in the second half, as it targets most of Arteris’ customer base working on advanced nodes.

2. Automotive OEM and Supply Chain Engagement

Direct OEM relationships have shifted the automotive business model, allowing Arteris to influence both automakers and their supply chains. This broadens the addressable market and creates pull-through demand, especially as car companies increasingly internalize chip design to support complex software architectures.

3. AI and RISC-V Ecosystem Penetration

Arteris’ wins with AI-focused customers like 10th Storrent and ASIC Land demonstrate traction in the emerging RISC-V and edge computing markets. The company’s IP is now embedded in over 150 machine learning chips, positioning it for future generative AI hardware cycles.

4. Product Portfolio Expansion via M&A

The Semifor acquisition augments Arteris’ offering with hardware-software interface IP, rounding out its integration suite and bolstering differentiation against internal and external competitors.

5. Resilient Model and Cost Discipline

High forward revenue visibility (75-80%) and ongoing OPEX management provide a cushion against macro volatility, with management emphasizing careful cash control and operating leverage from bookings growth.

Key Considerations

This quarter’s results signal that Arteris is executing on its dual strategy of deepening engagement with automotive OEMs and capitalizing on the AI hardware buildout, while product innovation and cost discipline anchor the model against external shocks.

Key Considerations:

  • Automotive Pull-Through Opportunity: Direct OEM wins can stimulate adoption across tiered suppliers, amplifying revenue potential.
  • AI Hardware Cycle Exposure: Early design wins in generative AI and RISC-V may unlock multi-year royalty streams as these chips reach production.
  • FlexNOC 5 Uptake: The success of FlexNOC 5’s rollout and its impact on ASPs will be a key determinant of H2 growth.
  • Macro and China Headwinds: Ongoing trade restrictions and credit tightening could pressure royalties and startup customer bookings.
  • Cash Flow Normalization: Management’s forecast for breakeven free cash flow for the remainder of the year depends on stable bookings and disciplined OPEX.

Risks

External risks remain significant: US-China trade restrictions, recessionary demand drag, and tighter credit conditions may dampen royalty growth and delay bookings, especially among startups. Execution risk on FlexNOC 5 adoption and automotive program ramps could impact the second-half inflection. Additionally, the competitive threat from internal IP teams and broader macro uncertainty persists, though Arteris’ product roadmap and customer diversity partly offset these exposures.

Forward Outlook

For Q2 2023, Arteris guided to:

  • ACV plus trailing 12-month royalties of $53.5 million to $57.5 million
  • Revenue of $13 million to $14 million

For full-year 2023, management reiterated guidance:

  • Revenue of $56 million to $60 million
  • ACV plus 12-month royalties exiting at $60.4 million to $65.4 million
  • Non-GAAP free cash flow margin of negative 9.7% to negative 19.7%

Management cited several drivers for confidence in the outlook:

  • FlexNOC 5 full production release expected to boost H2 revenues and ACV
  • Automotive and AI end-market resilience, with China activity expected to improve later in the year

Takeaways

Arteris is leveraging product innovation and deepening customer relationships to offset persistent macro and regional headwinds.

  • Automotive and AI are clear growth engines, with OEM and high-performance computing wins broadening the company’s base and supporting future royalty streams.
  • FlexNOC 5’s impact on ASPs and design wins will be central to delivering on the second-half acceleration embedded in guidance.
  • Investors should watch for FlexNOC 5 adoption rates, further OEM announcements, and signs of improvement in China and startup customer bookings as key forward indicators.

Conclusion

Arteris’ Q1 results and unchanged full-year guidance reflect a business balancing innovation-led growth with prudent cost management. The company’s ability to convert FlexNOC 5 and OEM engagement into sustained revenue and cash flow improvement will define its trajectory through 2023 and beyond.

Industry Read-Through

Arteris’ performance and commentary signal that demand for advanced NoC IP and SoC integration solutions is robust in automotive and AI, even as consumer and startup segments face macro drag. The direct engagement with OEMs and focus on RISC-V/AI hardware highlight a broader industry pivot toward vertical integration and specialized compute architectures. Competitors relying on internal IP development may face increased pressure to outsource, especially as cost and time-to-market pressures mount. For the semiconductor IP sector, the FlexNOC 5 launch and OEM pull-through model set a template for capturing value in next-gen chip design cycles.